SO-5 Disease-free survival as surrogate for overall survival in neoadjuvant chemo(radio)therapy treatment of esophageal or gastro-esophageal junction carcinoma: An analysis of 4518 individual patients and 22 trials

Autor: Cabrit, N., Faron, M., Tierney, J., Cheugoua-Zanetsie, M., Thirion, P., Cunningham, D., Winter, K., Fu, J., Mauer, M., Shapiro, J., Burmeister, B., Walsh, T., Piessen, G., Klevebro, F., Ychou, M., Van Der Gaast, A., Law, S., Stahl, M., Paoletti, X., Ducreux, M., Michiels, S.
Zdroj: In Annals of Oncology June 2022 33 Supplement 4:S358-S358
Databáze: ScienceDirect